deltatrials
Completed PHASE1 NCT00014430

Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer

Phase I Clinical Trial Of Vinorelbine (Navelbine) And Trastuzumab (Herceptin) In Patients With Carcinoma Of The Breast Or Non-Small Cell Lung Cancer And HER-2/NEU Overexpression

Sponsor: Dartmouth-Hitchcock Medical Center

Conditions Breast Cancer
Interventions trastuzumab vinorelbine ditartrate
Updated 5 times since 2017 Last updated: Mar 12, 2013 Started: Nov 30, 1999 Primary completion: Sep 30, 2002

This PHASE1 trial investigates Breast Cancer and is currently completed. Dartmouth-Hitchcock Medical Center leads this study, which shows 5 recorded versions since 1999 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1

    First recorded

Nov 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Dartmouth-Hitchcock Medical Center
  • National Cancer Institute (NCI)
Data source: Dartmouth-Hitchcock Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Lebanon, United States